Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obesity and Glucose Intolerance.

Diabetes Metab Syndr Obes · 2025 · PMC11971975 · PMID 40191829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Opaganib provided highly significant therapeutic benefit to both male and female mice in this model, indicating that it may be clinically effective in patients of either sex.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.